{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:11:37Z","timestamp":1792044697275,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ophtha.2015.02.033","type":"journal-article","created":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T00:22:37Z","timestamp":1429316557000},"page":"1452-1463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy"],"prefix":"10.1016","volume":"122","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Van Natta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice T.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Danis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2015.02.033_bib1","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2015.02.033_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archopht.121.1.99","article-title":"Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before the widespread availability of highly active antiretroviral therapy","volume":"121","author":"Holbrook","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2010.10.018","article-title":"Cytomegalovirus retinitis and the acquired immune deficiency syndrome: bench to bedside: LXVII Edward Jackson Memorial Lecture","volume":"151","author":"Jabs","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ophtha.2015.02.033_bib5","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ophtha.2015.02.033_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajo.2011.11.014","article-title":"Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"153","author":"Sugar","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2015.02.033_bib9","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994\u20131997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2015.02.033_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2015.02.033_bib11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/517399","article-title":"Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients","volume":"177","author":"Tural","year":"1998","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ophtha.2015.02.033_bib13","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/515281","article-title":"Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy","volume":"177","author":"Macdonald","year":"1998","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ophtha.2015.02.033_bib14","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.282.17.1633","article-title":"Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis","volume":"282","author":"Whitcup","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2015.02.033_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-137-4-200208200-00008","article-title":"Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy","volume":"137","author":"Kirk","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2015.02.033_bib16","first-page":"55","article-title":"Group guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ophtha.2015.02.033_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2011.04.007","article-title":"Evaluation of the United States Public Health Service guidelines for discontinuation of anti-cytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis","volume":"152","author":"Holbrook","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib18","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ophtha.2004.05.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib19","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2004.05.028","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib20","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ophtha.2010.03.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ophtha.2012.11.023","article-title":"Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy","volume":"120","author":"Jabs","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-148-3-200802050-00004","article-title":"Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy","volume":"148","author":"Braithwaite","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2015.02.033_bib23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"The Longitudinal Study of the Ocular Complications of AIDS: 1. Ocular diagnoses at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ophtha.2006.07.065","article-title":"The Longitudinal Study of the Ocular Complications of AIDS: 2. Ocular examination results at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"issue":"RR-17","key":"10.1016\/j.ophtha.2015.02.033_bib25","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"Centers for Disease Control and Prevention","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ophtha.2015.02.033_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0197-2456(92)90027-W","article-title":"The foscarnet ganciclovir cytomegalovirus retinitis treatment trial: 1. Rationale, design, and methods","volume":"13","author":"Studies of the Ocular Complications of AIDS Research Group","year":"1992","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ophtha.2015.02.033_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","article-title":"New visual acuity charts for clinical research","volume":"94","author":"Ferris","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ophtha.2010.09.017","article-title":"Visual field loss in patients with cytomegalovirus retinitis","volume":"118","author":"Thorne","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2007.08.039","article-title":"Loss of visual field among patients with birdshot chorioretinoapthy","volume":"145","author":"Thorne","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(00)00356-1","article-title":"Immune recovery uveitis in patients with cytomegalovirus retinitis following institution of successful highly active antiretroviral therapy","volume":"129","author":"Nguyen","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ophtha.2005.10.067","article-title":"Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis","volume":"113","author":"Kempen","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib33","unstructured":"Altman DG. Comparing groups-continuous data. In: Altman DG, ed. Practical Statistics for Medical Research. London: Chapman and Hall; 1991:213\u20135, 241\u201356."},{"key":"10.1016\/j.ophtha.2015.02.033_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.ophtha.2015.02.033_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/aje\/154.7.675","article-title":"Methods to assess population effectiveness therapies in human immunodeficiency virus incident and prevalent cohorts","volume":"154","author":"Tarwater","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib36","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/sim.4780132105","article-title":"Cox regression analysis of multivariate failure time data: the marginal approach","volume":"13","author":"Lin","year":"1994","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2015.02.033_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1115\/1.4010337","article-title":"A\u00a0statistical distribution function of wide applicability","volume":"18","author":"Weibull","year":"1951","journal-title":"J\u00a0Appl Mech Trans ASME"},{"key":"10.1016\/j.ophtha.2015.02.033_bib38","series-title":"Release 13","first-page":"285","year":"2013"},{"key":"10.1016\/j.ophtha.2015.02.033_bib39","first-page":"661","article-title":"Late HIV testing \u2013 34 states, 1996-2005","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ophtha.2015.02.033_bib40","first-page":"55","article-title":"Prevalence and indicators of viral suppression among persons diagnosed with HIV infection retained in care \u2013 Georgia, 2010","volume":"63","author":"Edison","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ophtha.2015.02.033_bib41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archopht.121.4.466","article-title":"Risk of vision loss in\u00a0patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome","volume":"121","author":"Kempen","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib42","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/379077","article-title":"Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome","volume":"37","author":"Kempen","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2015.02.033_bib43","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2006.03.021","article-title":"Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib44","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ophtha.2006.03.022","article-title":"Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(14)71645-9","article-title":"Rhegmatogenous retinal detachment in patients with\u00a0cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial","volume":"124","author":"Studies of Ocular Complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG)","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/bjo.2009.157727","article-title":"The epidemiology of rhegmatogenous retinal detachment: geographic variation and clinical associations","volume":"94","author":"Mitry","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.02.033_bib48","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2004.10.049","article-title":"Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy","volume":"112","author":"Jabs","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.02.033_bib49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/432012","article-title":"Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and the occurrence of resistant CMV in patients with CMV retinitis","volume":"192","author":"Jabs","year":"2005","journal-title":"J\u00a0Infect Dis"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201500175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201500175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T11:59:20Z","timestamp":1651751960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164201500175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S016164201500175X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2015.02.033","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2015.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}